These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18972439)

  • 1. Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.
    Berk PD
    Hepatology; 2008 Nov; 48(5):1362-76. PubMed ID: 18972439
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.
    Baou K; Vlachopoulos C; Manesis E; Archimandritis A; Stefanadis C
    Hellenic J Cardiol; 2007; 48(1):37-41. PubMed ID: 17388108
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.
    Musso G
    Endocrine; 2012 Oct; 42(2):237-9. PubMed ID: 22801991
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
    Kojima K; Shimada T; Nagareda Y; Watanabe M; Ishizaki J; Sai Y; Miyamoto K; Aburada M
    Biol Pharm Bull; 2011; 34(10):1613-8. PubMed ID: 21963504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.
    Nakao H; Yoneda M
    J Gastroenterol; 2009; 44(11):1162-4. PubMed ID: 19802516
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
    Bell DS
    South Med J; 2009 Oct; 102(10):991-2. PubMed ID: 19738529
    [No Abstract]   [Full Text] [Related]  

  • 7. NAFLD, NASH and liver cancer.
    Michelotti GA; Machado MV; Diehl AM
    Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):656-65. PubMed ID: 24080776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Soejima Y; Fukusato T
    World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of transcription factor modifications in the pathogenesis of insulin resistance.
    Kim MY; Bae JS; Kim TH; Park JM; Ahn YH
    Exp Diabetes Res; 2012; 2012():716425. PubMed ID: 22110478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption and fatty liver disease.
    Feng RN; Sun GD; Zhao Y; Guo FC; Sun CH
    World J Gastroenterol; 2013 Apr; 19(13):2129-30. PubMed ID: 23599638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipids in insulin resistance and type 2 diabetes mellitus development.
    Mingrone G; Castagneto M
    Nutrition; 1999 Jan; 15(1):64-6. PubMed ID: 9918070
    [No Abstract]   [Full Text] [Related]  

  • 14. The link between abdominal obesity and the metabolic syndrome.
    Phillips LK; Prins JB
    Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated membrane transport of free fatty acids in adipocytes: role in obesity and non-insulin dependent diabetes mellitus.
    Berk PD; Zhou SL; Bradbury M; Stump D; Kiang CL; Isola LM
    Trans Am Clin Climatol Assoc; 1997; 108():26-40; discussion 41-3. PubMed ID: 9108665
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease.
    Filik L
    Eur J Clin Invest; 2011 Dec; 41(12):1367; author reply 1368. PubMed ID: 21554270
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease.
    Leclercq I
    Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable effect of modest alcohol consumption to fatty liver disease.
    Hamaguchi M; Kojima T
    World J Gastroenterol; 2013 Aug; 19(32):5393-4. PubMed ID: 23983447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
    Cerasi E; Ktorza A
    Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.